Hypertension prevalence among US adults is rising and apparent treatment-resistant hypertension rates remain high.

A nationwide screening of non-communicable diseases conducted in February-March shows around nine percent of the population ...

Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

With one in four adults suffering from above-normal blood pressure levels in India, a new twice-yearly injectable, currently ...

A study was conducted to assess global trends in hypertension awareness, prevalence, treatment, and control between 2000 and 2020.

In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients ...

High blood pressure is treatable through medications and lifestyle changes but remains a leading cause of death in the United ...

A new study published in Circulation Research suggests that a specific brain region may play a key role in high blood ...

A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t ...

Hypertension is already of urgent concern in the US, where, in 2023, it contributed to an estimated 664,470 deaths.

Geared towards low-income patients with uncontrolled hypertension, a multifaceted, team-based implementation strategy for ...